{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:28:56Z","timestamp":1794277736053,"version":"4.9.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteoarthritis is a common and progressive degenerative joint disorder marked by cartilage degradation, subchondral bone remodeling, and chondrocyte apoptosis. Autophagy, a tightly regulated intracellular degradation process, is essential for maintaining chondrocyte homeostasis. Dysregulated autophagy can contribute to cartilage degeneration by disrupting the balance between cellular survival and death. The B-cell lymphoma 2 (BCL2) protein plays a dual role by inhibiting autophagy via its interaction with Beclin-1 while simultaneously suppressing apoptosis. This study aimed to investigate whether a therapeutic-grade purified exosome system derived from human plasma can modulate autophagy through regulation of BCL2 signaling, reduce chondrocyte apoptosis, and prevent osteoarthritis progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vitro experiments demonstrated that exosome treatment increased autophagic activity and reduced apoptosis in both immortalized and osteoarthritic human chondrocytes. Mechanistic analysis revealed that exosomes downregulated BCL2 expression, disrupted the BCL2\u2013Beclin-1 complex, and enhanced the expression of autophagy-related proteins LC3 and Beclin-1. Overexpression of BCL2 reversed these effects and led to impaired autophagic flux and elevated apoptosis, particularly in osteoarthritic chondrocytes. In a rat model of surgically induced osteoarthritis, intra-articular injection of the exosome product mixed with hyaluronic acid improved gait parameters, reduced mechanical pain sensitivity, and preserved cartilage architecture and subchondral bone structure. Histological and molecular analyses confirmed reduced chondrocyte apoptosis and elevated autophagic activity in exosome-treated joints, along with decreased BCL2 expression and complex formation with Beclin-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that a therapeutic-grade exosome formulation can alleviate osteoarthritis by restoring the balance between autophagy and apoptosis through modulation of the BCL2\u2013Beclin-1 signaling axis. These findings highlight the potential of exosome-based nanotherapeutics as a novel disease-modifying treatment strategy for degenerative joint disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-025-03807-y","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:14:55Z","timestamp":1764933295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A therapeutic-grade purified exosome system alleviates osteoarthritis by regulating autophagy through the BCL2\u2013Beclin1 axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Gongyin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atta","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"10360","key":"3807_CR1","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(22)01969-9","volume":"400","author":"Osteoarthritis","year":"2022","unstructured":"Osteoarthritis. 2022: advances in understanding, management, and challenges. Lancet. 2022;400(10360):1663\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(22)01969-9.","journal-title":"Lancet"},{"issue":"9","key":"3807_CR2","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00135-7","volume":"5","author":"regional Global","year":"2023","unstructured":"Global regional, national burden of osteoarthritis. 1990\u20132020, and projections to 2050: a systematic analysis for the global burden of disease study 2021. Lancet Rheumatol. 2023;5(9):e594\u2013605. https:\/\/doi.org\/10.1016\/S2665-9913(23)00135-7.","journal-title":"Lancet Rheumatol"},{"key":"3807_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03792-8","author":"Z Lv","year":"2021","unstructured":"Lv Z, et al. TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca(2+)\/CaMKII\/Nrf2 signaling pathway. Cell Death Dis. 2021. https:\/\/doi.org\/10.1038\/s41419-021-03792-8.","journal-title":"Cell Death Dis"},{"key":"3807_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2018.11.001","author":"LA Mandl","year":"2019","unstructured":"Mandl LA. Osteoarthritis year in review 2018: clinical. Osteoarthritis Cartilage. 2019. https:\/\/doi.org\/10.1016\/j.joca.2018.11.001.","journal-title":"Osteoarthritis Cartilage"},{"key":"3807_CR5","doi-asserted-by":"publisher","unstructured":"H\u00e9raud F, Harmand HA. Apoptosis in normal and Osteoarthritic human articular cartilage. Ann Rheum Dis. 2000 Dec. https:\/\/doi.org\/10.1136\/ard.59.12.959.","DOI":"10.1136\/ard.59.12.959"},{"key":"3807_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A","author":"S Hashimoto","year":"1998","unstructured":"Hashimoto S, et al. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 1998. https:\/\/doi.org\/10.1002\/1529-0131(199809)41:9%3C1632::AID-ART14%3E3.0.CO;2-A.","journal-title":"Arthritis Rheum"},{"key":"3807_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161125943","author":"HS Hwang","year":"2015","unstructured":"Hwang HS, Kim HA. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int J Mol Sci. 2015. https:\/\/doi.org\/10.3390\/ijms161125943.","journal-title":"Int J Mol Sci"},{"key":"3807_CR8","doi-asserted-by":"publisher","unstructured":"Lotz M, K\u00fchn HS. Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage. 1999 Jul. https:\/\/doi.org\/10.1053\/joca.1998.0220.","DOI":"10.1053\/joca.1998.0220"},{"key":"3807_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T","author":"FJ Blanco","year":"1998","unstructured":"Blanco FJ, et al. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum. 1998. https:\/\/doi.org\/10.1002\/1529-0131(199802)41:2%3C284::AID-ART12%3E3.0.CO;2-T.","journal-title":"Arthritis Rheum"},{"key":"3807_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/03008207.2016.1240790","author":"H Jeon","year":"2017","unstructured":"Jeon H, Im GI. Autophagy in osteoarthritis. Connect Tissue Res. 2017. https:\/\/doi.org\/10.1080\/03008207.2016.1240790.","journal-title":"Connect Tissue Res"},{"key":"3807_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052700","author":"MT Valenti","year":"2021","unstructured":"Valenti MT, et al. Control of the autophagy pathway in osteoarthritis: key regulators, therapeutic targets and therapeutic strategies. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22052700.","journal-title":"Int J Mol Sci"},{"key":"3807_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2019.1576811","author":"P Castrogiovanni","year":"2020","unstructured":"Castrogiovanni P, Ravalli S, Musumeci G. Apoptosis and autophagy in the pathogenesis of osteoarthritis. J Invest Surg. 2020. https:\/\/doi.org\/10.1080\/08941939.2019.1576811.","journal-title":"J Invest Surg"},{"key":"3807_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0909-y","author":"G Zheng","year":"2018","unstructured":"Zheng G, et al. TFEB, a potential therapeutic target for osteoarthritis via autophagy regulation. Cell Death Dis. 2018. https:\/\/doi.org\/10.1038\/s41419-018-0909-y.","journal-title":"Cell Death Dis"},{"key":"3807_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.614178","author":"M Colletti","year":"2020","unstructured":"Colletti M, et al. Autophagy and exosomes relationship in cancer: friends or foes? Front Cell Dev Biol. 2020. https:\/\/doi.org\/10.3389\/fcell.2020.614178.","journal-title":"Front Cell Dev Biol"},{"key":"3807_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-016-9696-y","author":"P Prathipati","year":"2017","unstructured":"Prathipati P, Nandi SS, Mishra PK. Stem cell-derived exosomes, autophagy, extracellular matrix turnover, and miRNAs in cardiac regeneration during stem cell therapy. Stem Cell Rev Rep. 2017. https:\/\/doi.org\/10.1007\/s12015-016-9696-y.","journal-title":"Stem Cell Rev Rep"},{"key":"3807_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061330","author":"A Brunel","year":"2021","unstructured":"Brunel A, et al. Autophagy and extracellular vesicles, connected to RabGTPase family, support aggressiveness in cancer stem cells. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10061330.","journal-title":"Cells"},{"key":"3807_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-00426-y","author":"L Salimi","year":"2020","unstructured":"Salimi L, et al. Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells. Cell Biosci. 2020. https:\/\/doi.org\/10.1186\/s13578-020-00426-y.","journal-title":"Cell Biosci"},{"key":"3807_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223623","author":"R Xie","year":"2022","unstructured":"Xie R, et al. Effects and mechanisms of exosomes from different sources in cerebral ischemia. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11223623.","journal-title":"Cells"},{"key":"3807_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.10.037","author":"W Yang","year":"2021","unstructured":"Yang W, et al. Mesenchymal stem-cell-derived exosomal miR-145 inhibits atherosclerosis by targeting JAM-A. Mol Ther. 2021. https:\/\/doi.org\/10.1016\/j.omtn.2020.10.037.","journal-title":"Mol Ther"},{"key":"3807_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000008202","author":"A Ikumi","year":"2021","unstructured":"Ikumi A, et al. Administration of purified exosome product in a rat sciatic serve reverse autograft model. Plast Reconstr Surg. 2021. https:\/\/doi.org\/10.1097\/PRS.0000000000008202.","journal-title":"Plast Reconstr Surg"},{"key":"3807_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000001005","author":"CK Kisby","year":"2021","unstructured":"Kisby CK, et al. Exosome-induced vaginal tissue regeneration in a porcine mesh exposure model. Female Pelvic Med Reconstr Surg. 2021. https:\/\/doi.org\/10.1097\/SPV.0000000000001005.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"3807_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24587","author":"J Qi","year":"2020","unstructured":"Qi J, et al. Characterization of a purified exosome product and its effects on canine flexor tenocyte biology. J Orthop Res. 2020. https:\/\/doi.org\/10.1002\/jor.24587.","journal-title":"J Orthop Res"},{"key":"3807_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121019","author":"Y Ren","year":"2021","unstructured":"Ren Y, et al. Effects of purified exosome product on rotator cuff tendon-bone healing in vitro and in vivo. Biomaterials. 2021. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121019.","journal-title":"Biomaterials"},{"key":"3807_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24859","author":"G Shi","year":"2021","unstructured":"Shi G, et al. A novel engineered purified exosome product patch for tendon healing: an explant in an ex vivo model. J Orthop Res. 2021. https:\/\/doi.org\/10.1002\/jor.24859.","journal-title":"J Orthop Res"},{"key":"3807_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/23259671211062929","author":"EP Wellings","year":"2021","unstructured":"Wellings EP, et al. Intrinsic tendon regeneration after application of purified exosome product: an in vivo study. Orthop J Sports Med. 2021. https:\/\/doi.org\/10.1177\/23259671211062929.","journal-title":"Orthop J Sports Med"},{"key":"3807_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2008.01.006","author":"SR Tew","year":"2008","unstructured":"Tew SR, et al. Cellular methods in cartilage research: primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods. 2008. https:\/\/doi.org\/10.1016\/j.ymeth.2008.01.006.","journal-title":"Methods"},{"issue":"9","key":"3807_CR27","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","volume":"15","author":"SS Glasson","year":"2007","unstructured":"Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse. Osteoarthritis Cartilage. 2007;15(9):1061\u20139. https:\/\/doi.org\/10.1016\/j.joca.2007.03.006.","journal-title":"Osteoarthritis Cartilage"},{"key":"3807_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2474-12-197","volume":"12","author":"M Pickarski","year":"2011","unstructured":"Pickarski M, Hayami T, Zhuo Y. Duong Le T. Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. BMC Musculoskelet Disord. 2011;12:197. https:\/\/doi.org\/10.1186\/1471-2474-12-197.","journal-title":"BMC Musculoskelet Disord"},{"key":"3807_CR29","doi-asserted-by":"publisher","unstructured":"Tsai PH, Ke TL, Chou CH et al. Dual roles of miR-140 in cartilage development and homeostasis. Sci Rep. 2017;7:10115. https:\/\/doi.org\/10.1038\/s41598-017-10412-w","DOI":"10.1038\/s41598-017-10412-w"},{"key":"3807_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jsp2.1014","author":"TW Evashwick-Rogler","year":"2018","unstructured":"Evashwick-Rogler TW, et al. Inhibiting tumor necrosis factor-alpha at time of induced intervertebral disc injury limits long-term pain and degeneration in a rat model. JOR Spine. 2018. https:\/\/doi.org\/10.1002\/jsp2.1014.","journal-title":"JOR Spine"},{"key":"3807_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223435","author":"A Lai","year":"2019","unstructured":"Lai A, et al. Dietary polyphenols as a safe and novel intervention for modulating pain associated with intervertebral disc degeneration in an in-vivo rat model. PLoS ONE. 2019. https:\/\/doi.org\/10.1371\/journal.pone.0223435.","journal-title":"PLoS ONE"},{"key":"3807_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2015.11.019","author":"A Lai","year":"2016","unstructured":"Lai A, et al. Annular puncture with tumor necrosis factor-alpha injection enhances painful behavior with disc degeneration in vivo. Spine J. 2016. https:\/\/doi.org\/10.1016\/j.spinee.2015.11.019.","journal-title":"Spine J"},{"key":"3807_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000003055","author":"GE Mosley","year":"2019","unstructured":"Mosley GE, et al. Sex differences in rat intervertebral disc structure and function following annular puncture injury. Spine (Phila Pa 1976). 2019. https:\/\/doi.org\/10.1097\/BRS.0000000000003055.","journal-title":"Spine (Phila Pa 1976)"},{"key":"3807_CR34","doi-asserted-by":"publisher","unstructured":"Miller CM, Enninga L, Rizzo EA, Phillipps SA, Guerrero-Cazares J, Destephano H, Peterson CC, Stalboerger TE, Behfar PG, Khan A. Platelet-derived exosomes induce cell proliferation and wound healing in human endometrial cells. Regen Med. 2022 Nov. https:\/\/doi.org\/10.2217\/rme-2022-0095.","DOI":"10.2217\/rme-2022-0095"},{"key":"3807_CR35","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEA.2023.0057","author":"L Mazzucchelli","year":"2023","unstructured":"Mazzucchelli L, Sarcon AK, Huang TCT, Li J, Berry CE, Houdek MT, et al. A ready-to-use purified exosome product for volumetric muscle loss and functional recovery. Tissue Eng Part A. 2023. https:\/\/doi.org\/10.1089\/ten.TEA.2023.0057.","journal-title":"Tissue Eng Part A"},{"key":"3807_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/bit.28520","author":"S Saffari","year":"2023","unstructured":"Saffari S, Rademakers DJ, Pulos N, Shin AY. Dose-response analysis after administration of a human platelet-derived exosome product on neurite outgrowth in vitro. Biotechnol Bioeng. 2023. https:\/\/doi.org\/10.1002\/bit.28520.","journal-title":"Biotechnol Bioeng"},{"key":"3807_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000001017","author":"CK Kisby","year":"2021","unstructured":"Kisby CK, Shadrin IY, Peng LT, Stalboerger PG, Trabuco EC, Behfar A, et al. Impact of repeat dosing and mesh exposure chronicity on exosome-induced vaginal tissue regeneration in a porcine mesh exposure model. Female Pelvic Med Reconstr Surg. 2021. https:\/\/doi.org\/10.1097\/SPV.0000000000001017.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"3807_CR38","doi-asserted-by":"publisher","unstructured":"Shi G, Long Z, De la Vega RE, Behfar A, Moran SL, Evans C, Zhao C. Purified exosome product enhances chondrocyte survival and regeneration by modulating inflammation and promoting chondrogenesis. Regen Med. 2023 Jan. https:\/\/doi.org\/10.2217\/rme-2022-0132.","DOI":"10.2217\/rme-2022-0132"},{"key":"3807_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2010.07965.x","author":"F Zhou","year":"2011","unstructured":"Zhou F, Yang Y, Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J. 2011. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07965.x.","journal-title":"FEBS J"},{"key":"3807_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2004-4","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zhang W, Guo X, Ren J, Gao A. The crosstalk between autophagy and apoptosis was mediated by phosphorylation of Bcl-2 and beclin1 in benzene-induced hematotoxicity. Cell Death Dis. 2019. https:\/\/doi.org\/10.1038\/s41419-019-2004-4.","journal-title":"Cell Death Dis"},{"key":"3807_CR41","doi-asserted-by":"publisher","DOI":"10.4161\/auto.6260","author":"B Levine","year":"2008","unstructured":"Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy. 2008. https:\/\/doi.org\/10.4161\/auto.6260.","journal-title":"Autophagy"},{"issue":"2","key":"3807_CR42","first-page":"214","volume":"2","author":"RT Marquez","year":"2012","unstructured":"Marquez RT, Xu L. Bcl-2: Beclin 1 complex: multiple, mechanisms regulating autophagy\/apoptosis toggle switch. Am J Cancer Res. 2012;2(2):214\u201321.","journal-title":"Am J Cancer Res"},{"key":"3807_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells1030284","author":"JP Decuypere","year":"2012","unstructured":"Decuypere JP, Parys JB, Bultynck G. Regulation of the autophagic bcl-2\/beclin 1 interaction. Cells. 2012. https:\/\/doi.org\/10.3390\/cells1030284.","journal-title":"Cells"},{"issue":"7708","key":"3807_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-018-0162-7","volume":"558","author":"\u00c1F Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez \u00c1F, Sebti S, Wei Y, Zou Z, Shi M, McMillan KL, et al. Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature. 2018;558(7708):136\u201340. https:\/\/doi.org\/10.1038\/s41586-018-0162-7.","journal-title":"Nature"},{"key":"3807_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2017.1390636","author":"J Liu","year":"2018","unstructured":"Liu J, Liu W, Lu Y, Tian H, Duan C, Lu L, et al. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy. 2018. https:\/\/doi.org\/10.1080\/15548627.2017.1390636.","journal-title":"Autophagy"},{"key":"3807_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2007.02.019","author":"T Nobukuni","year":"2007","unstructured":"Nobukuni T, Kozma SC, Thomas G. hVps34, an ancient player, enters a growing game: mTOR complex1\/S6K1 signaling. Curr Opin Cell Biol. 2007. https:\/\/doi.org\/10.1016\/j.ceb.2007.02.019.","journal-title":"Curr Opin Cell Biol"},{"key":"3807_CR47","doi-asserted-by":"publisher","unstructured":"Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, et al. Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1. EMBO J. 2007(10). https:\/\/doi.org\/10.1038\/sj.emboj.7601689.","DOI":"10.1038\/sj.emboj.7601689"},{"key":"3807_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.06.069","author":"W Feng","year":"2007","unstructured":"Feng W, Huang S, Wu H, Zhang M. Molecular basis of Bcl-xL\u2019s target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1. J Mol Biol. 2007. https:\/\/doi.org\/10.1016\/j.jmb.2007.06.069.","journal-title":"J Mol Biol"},{"key":"3807_CR49","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.2c00309","author":"X Dong","year":"2022","unstructured":"Dong X, Liang Q, Pan YZ, Wang X, Kuo YC, Chiang WC, et al. Novel Bcl-2 inhibitors selectively disrupt the autophagy-specific Bcl-2-Beclin 1 protein-protein interaction. ACS Med Chem Lett. 2022. https:\/\/doi.org\/10.1021\/acsmedchemlett.2c00309.","journal-title":"ACS Med Chem Lett"},{"key":"3807_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-0602-4_5","author":"HD Xu","year":"2019","unstructured":"Xu HD, Qin ZH. Beclin 1, Bcl-2 and autophagy. Adv Exp Med Biol. 2019. https:\/\/doi.org\/10.1007\/978-981-15-0602-4_5.","journal-title":"Adv Exp Med Biol"},{"key":"3807_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00137","author":"MB Menon","year":"2018","unstructured":"Menon MB, Dhamija S. Beclin 1 phosphorylation - at the center of autophagy regulation. Front Cell Dev Biol. 2018. https:\/\/doi.org\/10.3389\/fcell.2018.00137.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"3807_CR52","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.joca.2018.09.016","volume":"27","author":"PJ Cope","year":"2019","unstructured":"Cope PJ, Ourradi K, Lethbridge MW, et al. Models of osteoarthritis: the good, the bad and the promising. Osteoarthritis Cartilage. 2019;27(2):230\u20139. https:\/\/doi.org\/10.1016\/j.joca.2018.09.016.","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"3807_CR53","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13287-022-02888-4","volume":"13","author":"Y Zhuang","year":"2022","unstructured":"Zhuang Y, Li X, Zhan J, et al. Mesenchymal stem cell\u2013derived exosomes attenuate osteoarthritis progression in animal models: a systematic review and meta-analysis. Stem Cell Res Ther. 2022;13(1):220. https:\/\/doi.org\/10.1186\/s13287-022-02888-4.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3807_CR54","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13287-022-03022-0","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Kuang L, Chen C, et al. miR-100-5p\u2013enriched exosomes from human bone marrow mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting mTOR in osteoarthritis. Stem Cell Res Ther. 2022;13(1):322. https:\/\/doi.org\/10.1186\/s13287-022-03022-0.","journal-title":"Stem Cell Res Ther"},{"key":"3807_CR55","doi-asserted-by":"publisher","first-page":"1365890","DOI":"10.3389\/fbioe.2024.1365890","volume":"12","author":"P Luo","year":"2024","unstructured":"Luo P, Jiang C, Ji P, et al. Mesenchymal stem cell\u2013derived extracellular vesicles for osteoarthritis therapy: recent advances and future perspectives. Front Bioeng Biotechnol. 2024;12:1365890. https:\/\/doi.org\/10.3389\/fbioe.2024.1365890.","journal-title":"Front Bioeng Biotechnol"},{"key":"3807_CR56","doi-asserted-by":"publisher","first-page":"115150","DOI":"10.1016\/j.biopha.2024.115150","volume":"169","author":"MJ Alcaraz","year":"2024","unstructured":"Alcaraz MJ, Vicente-Rodr\u00edguez M, Guill\u00e9n MI. Extracellular vesicles from mesenchymal stem cells as novel treatments for osteoarthritis: targeting cartilage, subchondral bone and synovium. Biomed Pharmacother. 2024;169:115150. https:\/\/doi.org\/10.1016\/j.biopha.2024.115150.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3807_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12967-024-05072-3","volume":"22","author":"L Wen","year":"2024","unstructured":"Wen L, Tang J, Wang H, et al. Challenges and opportunities for mesenchymal stem cell\u2013derived extracellular vesicles in regenerative medicine: translational barriers and potential solutions. J Transl Med. 2024;22(1):55. https:\/\/doi.org\/10.1186\/s12967-024-05072-3.","journal-title":"J Transl Med"},{"issue":"39","key":"3807_CR58","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102(39):13944\u20139. https:\/\/doi.org\/10.1073\/pnas.0506654102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3807_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.47","volume":"3","author":"G Misso","year":"2014","unstructured":"Misso G, Di Martino MT, De Rosa G, et al. Mir-34: a new weapon against cancer? Mol Ther. 2014;3:e194. https:\/\/doi.org\/10.1038\/mtna.2014.47.","journal-title":"Mol Ther"},{"issue":"1","key":"3807_CR60","doi-asserted-by":"publisher","first-page":"247","DOI":"10.35248\/2167-7921.19.8.247","volume":"8","author":"M Zhang","year":"2019","unstructured":"Zhang M, Lygrisse KA, Wang J. Role of MicroRNA in osteoarthritis. J Arthritis. 2019;8(1):247. https:\/\/doi.org\/10.35248\/2167-7921.19.8.247.","journal-title":"J Arthritis"},{"issue":"6","key":"3807_CR61","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.3892\/etm.2019.8140","volume":"18","author":"Z Li","year":"2019","unstructured":"Li Z, Wang B, Zhang H, et al. MiR-146a regulates inflammation and cartilage degradation in osteoarthritis by targeting TRAF6 and IRAK1. Exp Ther Med. 2019;18(6):4852\u201360. https:\/\/doi.org\/10.3892\/etm.2019.8140.","journal-title":"Exp Ther Med"},{"issue":"11","key":"3807_CR62","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1101\/gad.1915510","volume":"24","author":"S Miyaki","year":"2010","unstructured":"Miyaki S, Sato T, Inoue A, et al. Microrna-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010;24(11):1173\u201385. https:\/\/doi.org\/10.1101\/gad.1915510.","journal-title":"Genes Dev"},{"issue":"12","key":"3807_CR63","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","volume":"65","author":"R Gastpar","year":"2005","unstructured":"Gastpar R, Gehrmann M, Bausero MA, et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 2005;65(12):5238\u201347. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3804.","journal-title":"Cancer Res"},{"key":"3807_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1468969","volume":"15","author":"DJ Beetler","year":"2025","unstructured":"Beetler DJ, Giresi P, Di Florio DN, et al. Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular content. Front Immunol. 2025;15:1468969. https:\/\/doi.org\/10.3389\/fimmu.2024.1468969.","journal-title":"Front Immunol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03807-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03807-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03807-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:03:31Z","timestamp":1768341811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03807-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3807"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03807-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research study titled \u201cPurified exosome products attenuate chondrocyte apoptosis by modulating autophagy to alleviate and treat osteoarthritis\u201d involving the use of Rats was conducted in strict accordance with the guidelines and principles set forth by \u201cMAYO CLINIC Institutional Animal Care and Use Committee\u201d. All experimental procedures, care, and handling of the animals were reviewed and formally approved by the MAYO CLINIC Institutional Animal Care and Use Committee, under approval number IACUC Protocol A00006568-22.\u00a0Utmost care was taken to ensure the welfare of the animals and minimize any distress. The number of animals used was kept to the minimum necessary for meaningful statistical analysis. Wherever possible, non-invasive techniques were employed, and efforts were made to ensure the animals\u2019 well-being throughout the study. After the study, all animals were humanely euthanized following the guidelines of the American Veterinary Medical Association (AVMA) Guidelines on Euthanasia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}